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Background: Gastro-esophageal reflux disease (GERD) predisposes to airway disease through a vagally-mediated
esophago-bronchial reflex. This study investigates this vagal response to esophageal acid perfusion.
Methods: 40 asthmatics with mild stable asthma participated. Each subject underwent spirometry and autonomic
function testing (valsalva maneuver, heart rate response to deep breathing and to standing from supine position)
four times: a) before intubation, b) after intubation, and then immediately after perfusion with, in random order, c)
concentrated lime juice solution (pH 2–3) and d) 0.9% saline. Subjects were blinded to the solution perfused.
Results: Asthmatics were of mean (SD) age 34.3 years (1.3), and 67.5% of them were females. pH monitoring
demonstrated that 20 subjects had abnormal reflux and 20 did not. In each group 10 subjects had a positive GERD
symptom score. Following perfusion with acid compared to saline, all subjects showed significant decreases in FEV1
and PEFR and significant increases in the mean valsalva ratio and heart rate difference on deep breathing from
baseline values, but no changes in FVC or heart rate ratio on standing. There were no significant differences in any
of the parameters between subjects with and without reflux.
Conclusions: Acid stimulation of the distal esophagus results in increased parasympathetic activity and
concomitant broncho-constriction in asthmatics irrespective of their reflux state. This strengthens the hypothesis
that GER triggers asthma-like symptoms through a vagally mediated esophago-bronchial reflex and encourages a
possible role for anti-cholinergic drugs in the treatment of reflux-associated asthma.
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Gastro-esophageal reflux disease (GERD) precipitates
airway hyper-responsiveness, lung function decrease and
asthma-like symptoms. The foregut and respiratory tract
have a common embryological origin [1]. It is possible
that inflammation in either leads to reflexes that mani-
fest clinically as asthma or GERD [2]. The pathway for
triggering ‘asthma-like’ symptoms is the vagal sensory
nerves innervating the airways and lungs [3]. The pro-
posed mechanisms are micro-aspiration of acid into air-
ways or an acid induced-esophago-bronchial reflex [4].* Correspondence: lakmaliamarasiri@gmail.com
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reproduction in any medium, provided the orMicroaspiration of refluxate damages epithelial cells
causing an inflammatory response in the airways of pa-
tients with GERD. Independent of aspiration, esophageal
acid reflux may cause an increase in vagal tone with
stimulation of vagal reflexes. Evidence for this vagal-
mediated reflex comes from acid perfusion studies [5].
These are performed to simulate the distal esophageal
response to acid, without allowing the acid to reflux
proximally thereby preventing proximal aspiration.
Gastro-esophageal reflux (GER) has been variously
reported to have an important effect [6,7], a small effect
[8-10] and no effect on pulmonary function [11-13]. Re-
gionally, two studies have reported an increase in airway
resistance [14] and decrease in forced expiratory volume
in the first second (FEV1) [15] following esophageal acid
perfusion. Several other studies have also demonstratedal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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matics with GER, intra-esophageal acid infusion caused
a decrease in peak expiratory flow rate (PEFR) and a
drink of dilute hydrochloric acid (HCl) significantly in-
creased airway sensitivity to inhaled histamine in child-
hood asthma, and this was abolished with pre-treatment
with atropine [20].
This suggested a vagal reflex as the most likely explan-
ation for increase in airway hyper-responsiveness and
shows that the vagus nerve is involved in the direct va-
gally mediated reflex, the heightened bronchial reactivity
mechanism and the microaspiration theory [1]. Asth-
matics with GERD have been shown to have a
hypervagal response [21].
The aim of our study was to study the vagal response
and pulmonary function in asthmatics following esopha-
geal acid perfusion.
Methods
The subjects were consecutive asthmatics (American
Thoracic Society criteria) [22] recruited from medical
clinics of the Colombo North Teaching Hospital,
Ragama, Sri Lanka, aged between 18–60 years, who were
did not smoke or abuse alcohol and were not diabetic.
Additional exclusion criteria were the presence of known
esophageal diseases, a history of previous upper gastro-
intestinal or pulmonary surgery, or presence of cardio-
vascular disease. All subjects gave informed written con-
sent before the study.
None of the subjects had had an exacerbation of
asthma in the two weeks preceding the study. They were
not on any drugs altering heart rate or blood pressure,
or if they were these were withheld for 24 hours prior to
testing. Oral asthma drugs were withheld for 24 hours
and inhaled drugs for 8 hours prior to the study,
allowing inhaled or nebulized beta-2 agonists on an as-
required basis. Acid suppressing medications were
discontinued 7 days and prokinetic agents 48 hours be-
fore the study. Antacids were stopped at midnight the
day before.
All subjects underwent baseline spirometry, stationary
esophageal manometry and 24- hour ambulatory pH
monitoring assessment. Spirometry was performed using
a portable hand-held spirometer (Micro Plus spirometer,
Micro Medical Limited, Rochester, UK). Forced vital
capacity (FVC), FEV1, and PEFR were recorded after
each forced expiratory effort. Stationary esophageal
manometry was performed using a water perfused sys-
tem (Synetics PC Polygraf system, Stockholm, Sweden)
according to standard methodology to determine the
position of the lower esophageal sphincter (LES). 24-
hour esophageal pH monitoring was performed using a
dual sensor monocrystalline antimony catheter (Synetics
Medical AB, Stolkholm, Sweden), according to standardmethodology. The distal sensor of the pH catheter was
positioned 5 cm above the superior border of the mano-
metrically determined LES and the proximal sensor
15 cm above the distal sensor. The presence of reflux
was assessed according to methodology of DeMeester
and Johnson [23] and proximal and distal reflux was de-
termined according to cut-off values derived from a
population of healthy controls (Table 1) [24].
The subjects were screened by a previously validated
GERD screening score assessing frequency and severity
of 7 common upper gastrointestinal symptoms on a 5-
point Likert scale. Symptoms included were 1) heartburn
2) regurgitation 3) upper abdominal or chest pain 4) ab-
dominal distension 5) dysphagia 6) cough and 7)
belching. A GERD score was calculated as the sum of
the products of frequency and severity of each symptom.
A cut of score of ≥ 12.5 was considered as a positive
GERD score [25].Vagal function assessment following esophageal
perfusion
The day following removal of the pH catheter, following
an overnight fast, a feeding tube (4 mm diameter) was
used to deliver acid to the distal esophagus. The tube
was inserted to 15 cm above the upper border of the
lower esophageal sphincter (LES). Heart rate and ECG
were monitored continuously. Blood pressure was mea-
sured manually at 15 minute intervals. Asthmatics
underwent vagal autonomic function testing and spirom-
etry after intubation (baseline) after a resting period of
30 minutes [21]).
The vagal autonomic function tests [26] performed
were:
a) Valsalva maneuver produced by sustaining a forced
expiration through a mouthpiece connected to a
manometer (40 mmHg) lasting 15 s, following a
deep inspiration
b) heart rate variation with quiet and deep breathing
(six breaths per minute)
c) heart rate response to standing from supine position
Acid perfusion was performed in a seated position.
Each subject underwent esophageal perfusion with a so-
lution of normal saline (0.9% Sodium chloride solution,
Baxter, India) or solution of concentrated lime juice
(pH 3) alternatively, at a rate of 2 mL/min for 10 minutes
[27], using a 50 mL syringe. The patients were not aware
of which solution they received. At the end of each infu-
sion period, the patients underwent repeat vagal func-
tion testing and spirometry. After each infusion and
investigation, a time interval of 1 hour was allowed dur-
ing which the subjects rested in the seated position.
Table 1 Acid exposure in the esophagus in healthy volunteers
Proximal sensor (n=16) Distal sensor (n=26)
Parameter Median (range) 95th percentile Median (range) 95th percentile
Total % time pH<4 0.07 (0-0.4) 0.4 0.4 (0.08-1.5) 1.5
% time pH<4 in upright position 0.02 (0-0.4) 0.4 0.2 (0-3.0) 3.0
% time pH<4 in supine position 0.12 (0-0.5) 0.5 0.4 (0.07-2.8) 2.8
Total no. of reflux episodes 6.0 (0-25.0) 25.0 18.0 (2.7-94.2) 94.2
No. of episodes ≥ 5 min 0 (0-1) 1.0 0 (0-2) 2.0
Duration of longest reflux, min 0.9 (0-7.8) 7.8 1.9 (0.5-20.6) 20.6
DeMeester score 0.95 (0.2-4.8) 4.8 3.35 (0.7-11.5) 11.5
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Demographic characteristics are given as mean ± standard
error (SE) and mean (standard deviation). Comparison of
data between groups was by unpaired or paired t-test as
appropriate. Repeated measures of analysis using a general
linear model were used to compare the results of the dif-
ferent continuous variables in the two perfusion periods.
Categorical variables were compared using the χ2 test orTable 2 Baseline characteristics of subjects
Asthmatics without reflux
Age, yrs 33.6 ± 1.9
Gender, (M:F) 9:11
BMI, (kg/m2) 20.6 ± 0.6
GERD symptom score (frequency x severity)* 22.0 ± 3.2
DeMeester score* 5.3 ± 0.9
Asthma severity* (no of subjects)
Mild intermittent 11
Mild persistent 6
Moderate or severe persistent 3






Spirometry results, mean ± SE
FVC (L) 3.3 ± 0.1
FEV1 (L) 2.7 ± 0.1
PEFR (L) 4.3 ± 0.2
Autonomic function testing results
HR ratio* 1.21 ± 0.04
HR difference 23.1 ± 1.8
Valsalva ratio 1.3 ± 0.1
BMI Body Mass Index, GERD gastro-esophageal reflux disease, FVC Forced Vital Capa
Flow Rate.
HR Ratio Heart rate ratio (30th beat/ 15th beat) on standing from supine position.
HR difference Heart rate difference between inspiration and expiration during deep
Valsalva ratio ratio of maximum heart rate during the valsalva maneuver to the ma
All values mean ± SE unless specified otherwise.
* P <0.05; asthmatics with reflux compared to asthmatics without reflux.the Fisher Exact test. HR Ratio =Heart rate ratio (30th
beat/ 15th beat) on standing from supine position, HR
Diff = Heart rate difference between inspiration and expir-
ation during deep breathing at 6 cycles per minute, VR =
ratio of maximum heart rate during the valsalva maneuver
to the maximum heart rate around the 20th beat after
stopping the maneuver. A P value of ≤ 0.05 was consid-
ered significant. All statistical analysis was performed(n=20) Asthmatics with reflux (n=20) All asthmatics (n=40)
34.9 ± 1.9 34.3 ± 1.3
6:14 15:25
20.5 ± 0.7 20.5 ± 0.4
30.5 ± 4.6 26.2 ± 2.9










3.1 ± 0.1 3.2 ± 0.1
2.6 ± 0.1 2.7 ± 0.1
4.1 ± 0.2 4.2 ± 0.1
1.1 ± 0.03 1.2 ± 0.02
1.1 ± 0.03 1.2 ± 0.02
23.1 ± 1.5 23.01 ± 1.2
1.2 ± 0.05 1.2 ± 0.04
city, FEV1 Forced Expiratory Volume in 1st second, PEFR Peak Expiratory
breathing at 6 cycles per minute.
ximum heart rate around the 20th beat after stopping the maneuver.
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Chicago, IL, USA).
This study was approved by the Ethics and Scientific
Review Committee of the Faculty of Medicine of the
University of Kelaniya, Ragama, Sri Lanka. All proce-
dures were conducted following written informed con-
sent and conform to the Declaration of Helsinki.
Results
Forty asthmatics were studied; 20 had abnormal reflux
on pH monitoring and 20 had no reflux. The two groups
of asthmatics with and without reflux were found to be
comparable for age, gender and body mass index
(Table 2). Of the 20 asthmatics with reflux, 10 scored
positive on the GERD symptom score and of the 20 with
no demonstrable reflux on pH monitoring, 10 had a
positive GERD symptom score. The pH monitoring
values of the subjects are given in Table 3.
The 40 subjects were randomised: 20 of them received
acid perfusion first followed by saline as the second per-
fusion and the other 20 received the perfusions in re-
verse order. Comparison of the data at the first and
second measurements in individual subjects showed that
the order in which the perfusion was given did not affect
results.
All asthmatics demonstrated a significant decrease in
FEV1 and PEFR from the baseline values following per-
fusion with acid when compared to saline. There was no
such change in FVC (Table 4). All asthmatics also
showed a significant increase in the mean valsalva ratio
and heart rate difference on deep breathing fromTable 3 24 hour pH monitoring data of subjects
SPRP
Proximal sensor (15cm above LES)
Total No of reflux episodes 100.0 ± 23.2
No of reflux episodes> 5min 5.8 ± 1.5
Longest reflux episode 71.5 ± 14.8
Total % of time pH<4 9.8 ± 3.4
% of time pH<4 in upright position 7.0 ± 2.8
% of time pH<4 in supine position 12.1 ± 5.3
Demeester score 45.2 ± 12.1
Distal sensor (5cm above LES)
Total No of reflux episodes 103.2 ± 20
No of reflux episodes> 5min 6.4 ± 0.9
Longest reflux episode 58.8 ± 15.2
Total % time pH<4 14.6 ± 4.5
% time pH<4 in upright position 9.7 ± 3.3
% time pH<4 in supine position 20.2 ± 6.2
Demeester score 57.0 ± 12.2
All values as mean ± SE.
SPRP GERD symptom positive, reflux positive, SPRN GERD symptom positive, reflux
negative, reflux negative.baseline values following perfusion with acid when com-
pared to saline. There was no change in heart rate ratio
on standing (Table 4).
There was no significant difference in the other vagal
or spirometry parameters among asthmatics with and
without reflux. The asthmatics with reflux had non-
significant trends for higher values in the other vagal
parameters and greater decreases in FEV1 and PEFR
compared to those without reflux (Table 5). Comparing
asthmatics with and without positive GERD symptom
scores also failed to demonstrate differences in any of
the parameters following acid or saline perfusion
(Table 5).
Discussion
Asthmatics have increased parasympathetic autonomic
activity [21,28,29] and GER predisposes to asthma-like
airway disease [4]. Studies have demonstrated decrease
in pulmonary function [9,14,15] and increase in bron-
chial hyperresponsiveness [16-19] in asthmatics and
showed that cholinergic blockade abolishes this response
[20]. A vagally-mediated esophago-bronchial reflex has
been suggested [30]. Asthmatics with GER have been
shown to have hyper-vagal activity too [21].
This study showed that asthmatics demonstrate a sig-
nificantly higher vagal and broncho-constrictory re-
sponse to artificially infused esophageal acid when
compared to normal saline. To our knowledge this is the
first study where vagal function tests have been
performed following esophageal acid infusion in
asthmatics.SPRN SNRP SNRN
14.7 ± 7.2 87.7 ± 25.3 12.1 ± 2.8
0.6 ± 0.3 3.7 ± 1.2 1.7 ± 0.6
13.0 ± 12.8 45.7 ± 17.3 2.9 ± 1.4
0.2 ± 0.05 4.9 ± 1.3 0.3 ± 0.07
0.2 ± 0.06 8.1 ± 2.1 0.3 ± 0.09
0.1 ± 0.0 5.3 ± 2.8 0.3 ± 0.2
3.7 ± 2.3 31.1 ± 7.3 2.8 ± 0.4
31.5 ± 7.3 64.9 ± 13.8 22.7 ± 7.2
10.8 ± 8.1 4.3 ± 0.9 1.6 ± 0.8
4.8 ± 1.7 51.2 ± 15.4 2.9 ± 1.1
0.7 ± 0.2 8.8 ± 2.0 0.5 ± 0.2
1.5 ± 0.7 7.5 ± 2.4 1.1 ± 0.7
0.7 ± 0.3 5.9 ± 2.0 0.5 ± 0.2
6.3 ± 1.3 31.4 ± 5.4 4.3 ± 1.2
negative, SNRP GERD symptom negative, reflux positive, SNRN GERD symptom







Saline versus acid perfusion
Spirometry (L/min)
FVC 3.2 ± 0.10 3.2 ± 0.10 3.2 ± 0.10 0.084
FEV1 2.7 ± 0.08 2.7 ± 0.08 2.6 ± 0.07 0.001
PEFR 4.2 ± 0.14 4.1 ± 0.15 4.0 ± 0.13 0.023
Vagal function tests
Valsalva ratio 1.26 ± 0.04 1.23 ± 0.03 1.31 ± 0.04 0.011
Heart rate ratio on standing from supine position 1.16 ± 0.02 1.14 ± 0.02 1.12 ± 0.02 0.612
Heart rate difference on deep breathing 23.09 ± 1.16 23.6 ± 1.16 26.0 ± 1.40 0.004
* Repeated measures analysis; All values as mean ± SE.
FVC Forced Vital Capacity, FEV1 Forced Expiratory Volume in 1st Second, PEFR Peak Expiratory Flow Rate.
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trend for a higher response to the other vagal tests and
lower spirometry values in response to esophageal acid
perfusion compared to those without reflux. However,
the change in values demonstrated after saline and acid
perfusion were minute and not significant. Further simi-
lar studies are required to assess the clinical significance
of these results.
A previous study investigating asthmatics with GER
noted that 73%, 31% and 6% demonstrated a hypervagal
response during a deep breathing manoeuvre, the Val-
salva maneuver, and a tilt test respectively. They sug-
gested that this hypervagal responsiveness may be
partially responsible for the airway responses to esopha-
geal acid [21].
The present study demonstrated that FEV1 and PEFR
significantly decreased after an intra-esophageal infusion
of acid compared to saline. In a similar study of patients
referred for esophageal complaints, FEV1 and the heart
rate was seen to significantly decrease after administra-
tion of normal saline and acid, however with noTable 5 Pulmonary and vagal function tests of asthmatics (ca
GERD symptom score following distal esophageal acid or sali
Asthmatics with reflux and a
negative GERD symptom score
(n=10)
Asthmatics with reflux and
positive GERD symptom sc
(n=10)
Saline Acid Saline Acid
FVC (L) 3.0 ± 0.2 3.0 ± 0.2 3.0 ± 0.2 3.0 ± 0.2
FEV1 (L) 2.6 ± 0.2 2.4 ± 0.1 2.6 ± 0.2 2.4 ± 0.2
PEFR (L/min) 4.1 ± 0.2 4.1 ± 0.2 4.2 ± 0.2 4.1 ± 0.2
HR Ratio 1.1 ± 0.02 1.1 ± 0.03 1.1 ± 0.02 1.1 ± 0.0
HR diff 23.7 ± 2.3 26.0 ± 2.8 23.7 ± 2.4 26.0 ± 2.
VR 1.2 ± 0.06 1.4 ± 0.1 1.2 ± 0.06 1.4 ± 0.0
All values as mean ± SE.
FVC Forced Vital Capacity, FEV1 Forced Expiratory Volume in 1st second, PEFR Peak
HR Ratio Heart rate ratio (30th beat/ 15th beat) on standing from supine position, H
breathing at 6 cycles per minute, VR ratio of maximum heart rate during the valsalv
the maneuver.statistical differences noted between saline and acid. This
response was ablated by cholinergic blockade,
supporting the theory of a vagally-mediated esophago-
bronchial reflex [20]. Other studies too have reported
significant changes in pulmonary function and bronchial
hyper-responsiveness following acid perfusion [14,31].
However, several studies have found that pulmonary
function does not change following acid perfusion. A
similar study investigating 43 patients with bronchial
asthma showed that esophageal acid perfusion itself did
not cause significant reduction in FEV1 but that patients
with bronchial hyperreactivity, demonstrated by
methacholine challenge showed a decrease. They sug-
gested that the esophago-bronchial reflex studied was
not present in patients without bronchial hyperreactivity
[32]. Another study investigating 20 asthmatics with re-
flux reported no change in bronchial responsiveness to
bradykinin following acid infusion [33]. A review of 18
studies of GER and acid perfusion in adult asthmatics
reported that in asthmatics with GER, the effects of acid




Asthmatics without reflux and
a negative GERD symptom
score (n=10)
Asthmatics without reflux and
a positive GERD symptom
score (n=10)
Saline Acid Saline Acid
3.4 ± 0.2 3.3 ± 0.2 3.1 ± 0.1 3.1 ± 0.1
2.8 ± 0.2 2.8 ± 0.1 2.6 ± 0.1 2.6 ± 0.1
4.1 ± 0.3 3.9 ± 0.2 3.8 ± 0.2 3.7 ± 0.2
3 1.2 ± 0.06 1.2 ± 0.05 1.0 ± 0.02 1.0 ± 0.03
8 22.0 ± 2.6 25.2 ± 3.2 24.8 ± 2.8 27.0 ± 3.1
9 1.2 ± 0.1 1.3 ± 0.1 1.3 ± 0.05 1.4 ± 0.09
Expiratory Flow Rate.
R Diff Heart rate difference between inspiration and expiration during deep
a maneuver to the maximum heart rate around the 20th beat after stopping
Amarasiri et al. BMC Pulmonary Medicine 2013, 13:33 Page 6 of 8
http://www.biomedcentral.com/1471-2466/13/33further stated that asthmatics without symptomatic GER
showed no change in spirometry, respiratory resistance
or flow-volume indices [5].
It has been suggested that the acid-induced increased
bronchial response is only demonstrable in ‘sensitive’
esophagi; that is the ‘damaged’ esophageal mucosa ex-
poses nerve endings that produce an augmented effect
[7]. Indeed, previous studies have shown significant in-
crease in airway resistance and decrease in PEF in asth-
matics with severe esophagitis [33], but no significant
changes in asthmatics without esophagitis [27]. Schan
et al. [9] showed that esophageal acid caused a decrease
in the PEFR and that esophageal mucosal inflammation
assessed by a positive Bernstein test was not required for
the airway responses. Though we did not assess endo-
scopic evidence of reflux in our subjects, we confirmed
presence of reflux by two other methods: prolonged am-
bulatory pH monitoring and a validated GERD symptom
score. 24 hour esophageal pH monitoring demonstrates
the highest sensitivity [34]. Lack of endoscopic evidence
is a limitation in the study. Our data also showed that
asthmatics demonstrate a decrease in FEV1 following
acid perfusion irrespective of reflux status.
We employed the criteria of abnormally increased dis-
tal sensor Demeester score as the cut-off to determine
reflux positive state. Based on this we had 10 subjects
per category. A previous study demonstrated that an in-
crease in the number of reflux events at the level of the
distal esophagus is detectable in the reflux induced
asthma, while the total score remains normal [35]. Fail-
ure to consider this is a limitation of the study.
Previous studies have demonstrated that a more
powerful stimulus of concentrated acid (0.1 N) instilled
into the esophagus in the presence of esophagitis can in-
duce an immediate increase in respiratory resistance [7]
and alteration in respiratory inductance [36]. The
present study was able to show a response even with a
lower, more physiological concentration of acid. It is un-
likely therefore, that the low concentration of acid used
in the present study contributed to the lack of significant
difference among parameters in asthmatics with and
without GER.
Wright et al.[20] reported that there was no difference
in airway flow in patients with pulmonary disease and in
those without respiratory complaints. Hence it was pos-
tulated that this cholinergic reflex is universal and
present in all individuals. A recent study reporting that
esophageal hypersensitivity could be induced and
maintained by repeated short duration acid infusion at
physiological pH levels (pH 1.8-4) in healthy subjects
confirms this statement [37]. Therefore, the response of
healthy controls to acid perfusion was not assessed in
the present study. The lack of data of healthy subjects
and non-asthmatic GERD patients is a limitation.In the present study, the esophageal catheter was
placed at 15 cm above the LES. This is a lower position
than in previous studies[19,30,38]. Ideally proximal and
distal intra-esophageal pH should have been measured
continuously to ensure that esophageal pH was neutral
during saline perfusion and low during acid perfusion.
We did not insert another probe, as an additional probe
would have added to the patients’ discomfort, reduced
patient compliance and increased the cost of the study
substantially. However esophageal acid clearance time in
the asthmatics was 0.08 seconds in the proximal esopha-
gus and 0.14 seconds in the distal esophagus. Therefore
we considered that the esophageal pH would have come
back to neutral levels during the time period of 2 hours
allowed between infusions. In one study investigating
airway hyper-responsiveness after acid perfusion, the
catheter was placed at a site 15 cm above the LES. Even
at this more proximal level of acid perfusion, the acid
did not reach the proximal esophagus [19]. Therefore,
though we had no facility to monitor the pH of the
upper part of the esophagus, it was unlikely that the
pharynx was stimulated by acid perfusion and that aspir-
ation of acid had an influence on the results.
None of our study subjects complained of pain during
the study (positive Bernstein test). It is possible that in-
fusion of the acid through a tube, bypassing taste input
and blinding the individual to the solution may have
resulted in this. Other studies have used lower pH values
for the acid perfusion study [10,19,25]. We used lime
juice at a pH of 2–3 which simulated gastric pH more
closely and is more physiological. This could be another
reason for the negative Bernstein test. Other studies
have also demonstrated a decline in PEFR following acid
perfusion that was independent of a positive Bernstein
test [9,10].
Pulmonary function testing by spirometry is effort-
dependent. Though there was concern that the presence
of the tube may have interfered with the results, there
was no difference between spirometry parameters before
and after intubation.
Conclusions
Acid stimulation of the distal esophagus results in in-
creased vagal activity and a concomitant broncho-
constriction in asthmatics irrespective of their reflux
state. This finding further strengthens the hypothesis
that GER may trigger asthma-like symptoms through a
vagally mediated esophago-bronchial reflex and suggests
a role for anti-cholinergic drugs in the treatment of
reflux-associated asthma.
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